IL5 and allergic bronchopulmonary aspergillosis: A pediatric patient with allergic bronchopulmonary mycosis with high-attenuation mucus and no fungal sensitization achieved remission with anti–IL-5 therapy, highlighting the diagnostic value of high-attenuation mucus and the role of eosinophilic inflammation in non–IgE-dominant airway disease.